biopharmaceutical
Emergent BioSolutions acquiring biopharmaceutical Cangene for $222M
Deal complements Emergent’s development of vaccines and therapeutics.
ProMetic and SSB expand their plasma purification efforts
Expanded strategic deal includes equipment and co-commercialization.
ProMetic extends its reach in Asian markets with $21M deal
R&D project will expand Shenzhen Hepalink’s product line and diversification efforts.
ProMetic turns loss around in Q2
Doubles revenues, records a profit of $800,000
ProMetic, NantPharma form US biopharmaceutical company
NantPro will manufacture plasma-derived product for US market.
ProMetic gets $4.6M Octapharma order
PrioClear prion capture resin is used in plasma product production.